(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-1.22%) $81.62
(-2.86%) $1.972
(-2.28%) $2 304.00
(-3.91%) $26.58
(-1.48%) $947.25
(0.49%) $0.937
(1.14%) $11.11
(0.53%) $0.800
(0.15%) $93.44
Live Chart Being Loaded With Signals
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction...
Stats | |
---|---|
今日成交量 | 508 370 |
平均成交量 | 331 175 |
市值 | 31.19M |
EPS | $0 ( 2024-04-02 ) |
下一个收益日期 | ( $0 ) 2024-05-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.850 |
ATR14 | $0.0630 (1.70%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-05 | Isaac Antonios | Buy | 125 787 | Common Stock |
2023-01-05 | Johnson Virland A | Buy | 78 617 | Common Stock |
2021-05-24 | Johnson Virland A | Sell | 32 933 | Common Shares |
2020-11-03 | Johnson Virland A | Sell | 1 469 | Common Stock |
2021-02-05 | Johnson Virland A | Sell | 4 112 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 96 transactions |
Buy: 2 390 604 | Sell: 701 030 |
音量 相关性
Janone Inc 相关性 - 货币/商品
Janone Inc 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-1.50M (0.00 %) |
EPS: | $-5.01 |
FY | 2023 |
营收: | $0 |
毛利润: | $-1.50M (0.00 %) |
EPS: | $-5.01 |
FY | 2022 |
营收: | $39.61M |
毛利润: | $7.62M (19.23 %) |
EPS: | $1.140 |
FY | 2021 |
营收: | $40.02M |
毛利润: | $8.87M (22.16 %) |
EPS: | $-6.35 |
Financial Reports:
No articles found.
Janone Inc
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。